Greytown Advisors Inc. Abb Vie Inc. Transaction History

Greytown Advisors Inc.

$169 Million
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $80,069 - $91,232	-501 Reduced 21.29%	1,852 $337,000
Q3 2023 Nov 06, 2023	SELL	$133.59 - $154.65 $279,069 - $323,063	-2,089 Reduced 47.03%	2,353 $350,000
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $13,159 - $15,155	-91 Reduced 2.01%	4,442 $707,000
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $120,468 - $144,472	-871 Reduced 16.12%	4,533 $733,000
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $110,052 - $126,222	-820 Reduced 13.17%	5,404 $725,000
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $124,821 - $158,688	-907 Reduced 12.72%	6,224 $953,000
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $536,762 - $665,971	-4,067 Reduced 36.32%	7,131 $1.16 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $14,932 - $18,894	-139 Reduced 1.23%	11,198 $1.52 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $80,651 - $91,551	-758 Reduced 6.27%	11,337 $1.22 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $399,482 - $445,046	3,797 Added 45.76%	12,095 $1.36 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $47,467 - $52,255	464 Added 5.92%	8,298 $898,000
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $192,934 - $260,481	2,397 Added 44.09%	7,834 $839,000
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $81,958 - $96,191	-954 Reduced 14.93%	5,437 $476,000
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $259,729 - $347,557	-3,540 Reduced 35.65%	6,391 $627,000
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $144,931 - $219,734	-2,247 Reduced 18.45%	9,931 $757,000
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $10,819 - $13,537	-150 Reduced 1.22%	12,178 $1.08 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $90,628 - $108,961	1,439 Added 13.22%	12,328 $933,000
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $715,407 - $914,458	10,889 New	10,889 $792,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greytown Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Greytown Advisors Inc. with notifications on news.

Account